VIVA BIOTECH (01873) spent 404,500 Hong Kong dollars to repurchase 450,000 shares on November 15th.
Viva Biotech (01873) announced that the company spent 404,500 Hong Kong dollars on November 15, 2024...
VIVA BIOTECH (01873) announces that the company has repurchased 450,000 shares on November 15, 2024, at a total cost of 404,500 Hong Kong dollars, with a repurchase price per share ranging from 0.89 to 0.9 Hong Kong dollars.
Related Articles
Kingfa Sci. & Tech. (600143.SH) is planning to launch an employee stock ownership plan in 2026.
Kingfa Sci. & Tech. (600143.SH) plans to issue up to 39,279,970 restricted shares.
New Stock News | Red Avenue New Materials Group (603650.SH) submits its application to the Hong Kong Stock Exchange. In the first nine months of 2025, its sales revenue in the Chinese semiconductor photoresist market ranked first among Chinese suppliers.
Kingfa Sci. & Tech. (600143.SH) is planning to launch an employee stock ownership plan in 2026.
Kingfa Sci. & Tech. (600143.SH) plans to issue up to 39,279,970 restricted shares.
New Stock News | Red Avenue New Materials Group (603650.SH) submits its application to the Hong Kong Stock Exchange. In the first nine months of 2025, its sales revenue in the Chinese semiconductor photoresist market ranked first among Chinese suppliers.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
